Citable filing context

CI filing events and research context

Server-rendered

CI's research view summarizes recent SEC filing context, starting with mda_quarterly from Apr 30, 2026.

CI filing events and research context
FiledItemContext
Apr 30, 2026mda_quarterlyShareholders' net income rose 25% to $1.65 billion in the first quarter of 2026, with adjusted income from operations increasing 12% to $2.06 billion. Evernorth Health Services reported a 9% increase in adjusted revenues to $58.4 billion, driven by pharmacy claims composition and customer growth in Specialty and Care Services. Cigna Healthcare adjusted revenues declined 21% to $11.5 billion, primarily due to the divestiture of Medicare Advantage and related businesses via the HCSC transaction. Despite this, the segment's pre-tax adjusted income grew 18% to $1.51 billion, supported by improved margins in U.S. Employer and Individual and Family Plans and a 240-basis point decrease in the medical care ratio to 79.8%. The company is executing a Strategic Optimization Program through 2028, incurring $380 million in pre-tax costs this quarter, largely from severance. Key financial risks include the Inflation Reduction Act's negative impact on operating cash flows and a 25% exposure to the office sector within its $1.3 billion commercial mortgage loan portfolio. The debt-to-capitalization ratio stood at 42.3%, and the company paused share repurchases during the period.
Feb 26, 2026businessThe Cigna Group operates as a global health company divided into two primary segments: Evernorth Health Services and Cigna Healthcare. Evernorth provides pharmacy benefit management through Express Scripts and specialty pharmacy services via Accredo, alongside virtual care and benefits management through MD Live and EviCore. A strategic shift toward a transparent, rebate-free pharmacy model is slated for full implementation by 2028. Cigna Healthcare delivers U.S. and international medical plans utilizing both administrative services only (ASO) and insured funding models; notably, the company divested its Medicare Advantage and related businesses to Health Care Service Corporation in March 2025. The company is aggressively integrating augmented intelligence and predictive analytics to optimize care and operational efficiency. Financial analysts should note significant revenue concentration, as a single pharmacy benefit client accounted for approximately 19% of total external revenue in 2025. The business faces substantial regulatory oversight from agencies including CMS, HHS, and the DOL, where legislative changes to government-reimbursed programs or enforcement actions could materially impact profitability, brand reputation, and licensure.
Feb 26, 2026mdaThe Cigna Group operates through two primary segments: Evernorth Health Services, featuring Express Scripts and Accredo, and Cigna Healthcare, which provides U.S. and international medical plans. A pivotal strategic shift includes the March 2025 sale of its Medicare Advantage and CareAllies businesses to Health Care Service Corporation. The company is currently transitioning to a transparent, rebate-free pharmacy benefit model, targeting full implementation for Evernorth clients by 2028. Financial analysts should note the significant $73.5 billion in goodwill and intangibles, which recently contributed to a $2.7 billion impairment loss on VillageMD. Total indebtedness stands at approximately $31.5 billion. Key regulatory risks center on the Consolidated Appropriations Act 2026, which mandates that PBMs remit 100% of certain rebates to plan sponsors by August 2028 and restricts Medicare Part D compensation. Operational risks include cybersecurity vulnerabilities—highlighted by the Change Healthcare ransomware attack—and the integration of generative AI into claims processing. Profitability remains highly sensitive to medical cost pricing accuracy, the stability of relationships with large retail pharmacy chains, and the evolving regulatory landscape surrounding PBM transparency and drug pricing.

Source: SEC EDGAR filing text and events; period Apr 30, 2026; filed Apr 30, 2026.

Continue research

Keep researching CI

Follow same-sector companies and source explainers connected to the research view.

Browse Health Care

Related tickers

LLY
Lilly (Eli)
$1.02T
Health Care
Open company page →
JNJ
Johnson & Johnson
$558.88B
Health Care
Open company page →
ABBV
AbbVie
$393.91B
Health Care
Open company page →
UNH
UnitedHealth Group
$369.32B
Health Care
Open company page →
MRK
Merck & Co.
$295.00B
Health Care
Open company page →
AZN
ASTRAZENECA PLC
$281.75B
Health Care
Open company page →

Related explainers

Understanding 8-K filings

A factual guide to SEC Form 8-K current reports and the material company events they can disclose between quarterly filings.

Read explainer →
Reading a 10-Q

A factual guide to quarterly SEC Form 10-Q reports, how they differ from annual 10-K filings, and what readers can inspect first.

Read explainer →
S-1 and the IPO prospectus

A factual guide to Form S-1 registration statements and the disclosures companies provide before a public offering.

Read explainer →
Reading an SEC 10-K

A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.

Read explainer →